We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Countdown to Privia Health (PRVA) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS
Read MoreHide Full Article
Analysts on Wall Street project that Privia Health (PRVA - Free Report) will announce quarterly earnings of $0.06 per share in its forthcoming report, representing an increase of 200% year over year. Revenues are projected to reach $455.65 million, increasing 9.7% from the same quarter last year.
The consensus EPS estimate for the quarter has undergone a downward revision of 4% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
In light of this perspective, let's dive into the average estimates of certain Privia Health metrics that are commonly tracked and forecasted by Wall Street analysts.
The combined assessment of analysts suggests that 'Practice Collections' will likely reach $780.88 million. Compared to the current estimate, the company reported $707.70 million in the same quarter of the previous year.
The consensus among analysts is that 'Care Margin' will reach $106.25 million. The estimate is in contrast to the year-ago figure of $94.90 million.
The collective assessment of analysts points to an estimated 'Platform Contribution' of $50.60 million. The estimate is in contrast to the year-ago figure of $44.70 million.
Shares of Privia Health have experienced a change of +4.5% in the past month compared to the +10.6% move of the Zacks S&P 500 composite. With a Zacks Rank #4 (Sell), PRVA is expected to underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Countdown to Privia Health (PRVA) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS
Analysts on Wall Street project that Privia Health (PRVA - Free Report) will announce quarterly earnings of $0.06 per share in its forthcoming report, representing an increase of 200% year over year. Revenues are projected to reach $455.65 million, increasing 9.7% from the same quarter last year.
The consensus EPS estimate for the quarter has undergone a downward revision of 4% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
In light of this perspective, let's dive into the average estimates of certain Privia Health metrics that are commonly tracked and forecasted by Wall Street analysts.
The combined assessment of analysts suggests that 'Practice Collections' will likely reach $780.88 million. Compared to the current estimate, the company reported $707.70 million in the same quarter of the previous year.
The consensus among analysts is that 'Care Margin' will reach $106.25 million. The estimate is in contrast to the year-ago figure of $94.90 million.
The collective assessment of analysts points to an estimated 'Platform Contribution' of $50.60 million. The estimate is in contrast to the year-ago figure of $44.70 million.
View all Key Company Metrics for Privia Health here>>>
Shares of Privia Health have experienced a change of +4.5% in the past month compared to the +10.6% move of the Zacks S&P 500 composite. With a Zacks Rank #4 (Sell), PRVA is expected to underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>